What is the 13F Pro Quality Score for LUCY?

13F Pro ranks Innovative Eyewear Inc (LUCY) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View LUCY's current score at https://13fpro.ai/research/LUCY (free sign-up required for the full ranking).

Where does 13F Pro source LUCY data?

All Innovative Eyewear Inc fundamentals and ownership data come directly from SEC EDGAR. Innovative Eyewear Inc files with the SEC under CIK 1808377. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is LUCY in?

Innovative Eyewear Inc (LUCY) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is LUCY research updated on 13F Pro?

LUCY's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Innovative Eyewear Inc(LUCY)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1808377 LUCY stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $2.7M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

LUCY Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Innovative Eyewear Inc (LUCY), a Healthcare sector company. LUCY is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $2.7m in revenue. Based on the latest XBRL financial filings (Q1 2026), Innovative Eyewear Inc reports quarterly revenue of $773.6K, net income of $-2.3M, free cash flow of $-2.5M. Top institutional holders of LUCY by reported 13-F value include Cetera Investment Advisers, GEODE CAPITAL MANAGEMENT,, KEYBANK NATIONAL ASSOCIATION/OH, based on the most recent SEC filings. LUCY trades on the Nasdaq exchange and files with the SEC under CIK 1808377. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LUCY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Innovative Eyewear Inc directly from SEC EDGAR.

Revenue

Q1 2026

$773.6K

Net Income

Q1 2026

$-2.3M

Free Cash Flow

Q1 2026

$-2.5M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+148.0% YoY

$1.6MFY 2024

FY21 $690.7KFY22 $659.8KFY24 $1.6M

Net Income

-36.7% YoY

$-7.8MFY 2024

FY21 $-3.2MFY22 $-5.7MFY24 $-7.8M

EPS (Diluted)

-496.6% YoY

$-2.60FY 2024

FY21 —FY22 $-0.43FY24 $-2.60

Total Assets

+109.8% YoY

$9.8MFY 2024

FY21 $824.3KFY22 $4.7MFY24 $9.8M

Op. Cash Flow

-109.0% YoY

$-6.7MFY 2024

FY21 $-1.2MFY22 $-3.2MFY24 $-6.7M

Metric	FY 2024	FY 2022	FY 2021
Revenue	$1.6M +148.0%	$659.8K -4.5%	$690.7K
Net Income	$-7.8M -36.7%	$-5.7M -75.1%	$-3.2M
EPS (Diluted)	$-2.60 -496.6%	$-0.43	—
Total Assets	$9.8M +109.8%	$4.7M +468.9%	$824.3K
Operating Cash Flow	$-6.7M -109.0%	$-3.2M -165.6%	$-1.2M

AI Insight: LUCY Financial Trends

Innovative Eyewear remains pre-revenue with flat $1M quarterly sales and persistent $2M net losses; cash burn stabilizing but business model unproven.

• Revenue flat at $1M per quarter since Q4 2024; no growth trajectory evident over 5 quarters.

• Net losses steady at $2M per quarter across all 8 quarters; no path to profitability visible.

• Operating cash outflow averaging $1.6M quarterly; equity buffer declined from $11M (Q3 2024, Q2 2025) to $8M (Q1 2026).

⚠ Equity erosion of $3M over 10 months; runway at current burn rate approximately 4 quarters without additional capital.

⚠ Operating income and total debt unreported; obscures leverage and cost structure clarity.

AI Insight: LUCY Ratio Trends

Innovative Eyewear remains deeply unprofitable with deteriorating returns; ROE fell to -110.4% in Q1 2026, reversing fragile Q3 2025 improvement.

• ROE and ROA consistently negative across all periods; Q1 2026 ROE of -110.4% marks worst quarter since Q2 2024's -106.1%.

• Modest improvement visible Q2–Q3 2025 (ROE improved from -94.9% to -71.7%), but gains fully reversed in Q4 2025–Q1 2026.

• NPM data sparse; Q4 2025 NPM of -194.8% indicates severe operating losses relative to revenue.

⚠ Sharp Q1 2026 deterioration (ROE -110.4%, ROA -97.4%) suggests underlying operational breakdown; investigate root cause.

⚠ No operating or profitability margins reported; inability to isolate margin drivers complicates diagnosis of path to profitability.

Get alerted when LUCY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Innovative Eyewear Inc including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of LUCY

Cetera Investment Advisers
$545.0K500,000 sh
GEODE CAPITAL MANAGEMENT, LLC
$65.4K60,517 sh
KEYBANK NATIONAL ASSOCIATION/OH
$16.4K15,000 sh
Clear Street Group Inc.
$8.2K115,221 sh
Tower Research Capital LLC (TRC)
$1.9K1,759 sh
CITADEL ADVISORS LLC
$1.8K28,103 sh
BRAVE ASSET MANAGEMENT INC
$1.7K31,388 sh
JONES FINANCIAL COMPANIES LLLP
$663.00614 sh
WELLS FARGO & COMPANY/MN
$327.00300 sh
UBS Group AG
$5.0083 sh

Fund	Value	Shares
Cetera Investment Advisers	$545.0K	500,000
GEODE CAPITAL MANAGEMENT, LLC	$65.4K	60,517
KEYBANK NATIONAL ASSOCIATION/OH	$16.4K	15,000
Clear Street Group Inc.	$8.2K	115,221
Tower Research Capital LLC (TRC)	$1.9K	1,759
CITADEL ADVISORS LLC	$1.8K	28,103
BRAVE ASSET MANAGEMENT INC	$1.7K	31,388
JONES FINANCIAL COMPANIES LLLP	$663.00	614
WELLS FARGO & COMPANY/MN	$327.00	300
UBS Group AG	$5.00	83

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put LUCY on your watchlist

Track score changes the day Innovative Eyewear Inc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is LUCY a good stock to buy?

13F Pro's AI-powered analysis of Innovative Eyewear Inc (LUCY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for LUCY are available on the LUCY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own LUCY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling LUCY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Innovative Eyewear Inc's investment landscape.